VitroScreen at the 65th AFI Symposium

VitroScreen will participate in the 65th AFI Symposium, held from June 10 to 12 at the Palacongressi in Rimini, together with the SenzaGen Group at Booth #5.

The event will provide an important opportunity to present VitroScreen's expertise in advanced non-animal testing strategies supporting regulatory compliance and product development across multiple industries, including pharmaceuticals and medical devices.

As part of the SenzaGen Group, VitroScreen will showcase a comprehensive range of scientific and regulatory services, including:

A key focus of this year's participation will be the presentation of two scientific posters dedicated to innovative approaches for non-animal efficacy testing of substance-based medical devices. Both contributions highlight the value of human-relevant 3D models and advanced in vitro methodologies in generating robust efficacy data and supporting stronger scientific claims:

Poster #8: Assessment of the Film-Forming Effect of Substance-Based Medical Devices on Reconstructed Human Epithelia In Vitro (authors Francesca Rescigno PhD and Giacomo Masi)

Explores the assessment of film-forming properties of substance-based medical devices using reconstructed human epithelia in vitro.
The study demonstrates how advanced human-relevant models can support reliable efficacy evaluation while contributing to the transition toward non-animal testing strategies aligned with evolving regulatory expectations.

Poster #9: A 3D Human Prostatic Spheroids Model for the Preclinical Assessment of API Penetration and Metabolic Conversion (authors Francesca Rescigno PhD and Giacomo Masi)

Presents an innovative 3D human prostatic spheroids model designed for the preclinical evaluation of API penetration and metabolic conversion.

The research highlights the potential of spheroid-based platforms, including VitroScreenORA®, to generate physiologically relevant data capable of improving the predictive value of efficacy assessments and supporting robust product claims.

The posters will be presented by Giacomo Masi and Massimo Di Gabriele

Visit VitroScreen and the SenzaGen Group at Booth #5
AFI Symposium 2026 in Rimini